Nalmefene Implant in Healthy Subjects

NCT07325279 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ReacX Pharmaceuticals, Inc.

Collaborators